BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Miyazaki I, Asanuma M. Neuron-Astrocyte Interactions in Parkinson's Disease. Cells 2020;9:E2623. [PMID: 33297340 DOI: 10.3390/cells9122623] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 13.0] [Reference Citation Analysis]
Number Citing Articles
1 Prunell G, Olivera-bravo S. A Focus on Astrocyte Contribution to Parkinson’s Disease Etiology. Biomolecules 2022;12:1745. [DOI: 10.3390/biom12121745] [Reference Citation Analysis]
2 Zaman V, Drasites KP, Myatich A, Shams R, Shields DC, Matzelle D, Haque A, Banik NL. Inhibition of Calpain Attenuates Degeneration of Substantia Nigra Neurons in the Rotenone Rat Model of Parkinson’s Disease. IJMS 2022;23:13849. [DOI: 10.3390/ijms232213849] [Reference Citation Analysis]
3 Nam M, Sung Y, Jeong GH, Yoo S, Rhim H. HtrA2 regulates α-Synuclein-mediated mitochondrial reactive oxygen species production in the mitochondria of microglia. Biochemical and Biophysical Research Communications 2022. [DOI: 10.1016/j.bbrc.2022.11.049] [Reference Citation Analysis]
4 Zhang N, Yu X, Song L, Xiao Z, Xie J, Xu H. Ferritin confers protection against iron-mediated neurotoxicity and ferroptosis through iron chelating mechanisms in MPP+-induced MES23.5 dopaminergic cells. Free Radical Biology and Medicine 2022. [DOI: 10.1016/j.freeradbiomed.2022.11.018] [Reference Citation Analysis]
5 Liu Y, Guo Z, Zhu R, Gou D, Jia P, Pei D. An insight into sex-specific neurotoxicity and molecular mechanisms of DEHP: A critical review. Environmental Pollution 2022. [DOI: 10.1016/j.envpol.2022.120673] [Reference Citation Analysis]
6 Brandebura AN, Paumier A, Onur TS, Allen NJ. Astrocyte contribution to dysfunction, risk and progression in neurodegenerative disorders. Nat Rev Neurosci 2022. [DOI: 10.1038/s41583-022-00641-1] [Reference Citation Analysis]
7 Goloborshcheva VV, Kucheryanu VG, Voronina NA, Teterina EV, Ustyugov AA, Morozov SG. Synuclein Proteins in MPTP-Induced Death of Substantia Nigra Pars Compacta Dopaminergic Neurons. Biomedicines 2022;10:2278. [DOI: 10.3390/biomedicines10092278] [Reference Citation Analysis]
8 Hong DG, Lee S, Kim J, Yang S, Lee M, Ahn J, Lee H, Chang S, Ha N, Lee J. Anti-Inflammatory and Neuroprotective Effects of Morin in an MPTP-Induced Parkinson’s Disease Model. IJMS 2022;23:10578. [DOI: 10.3390/ijms231810578] [Reference Citation Analysis]
9 Dong Z, Zhan T, Sun H, Wang J, Duan G, Zhang Y, Chen Y, Huang Y, Xu S. Astrocytic ERK/STAT1 signaling contributes to maintenance of stress-related visceral hypersensitivity in rats. J Pain 2022:S1526-5900(22)00365-0. [PMID: 35914642 DOI: 10.1016/j.jpain.2022.07.006] [Reference Citation Analysis]
10 Te Vruchte D, Sturchio A, Priestman DA, Tsitsi P, Hertz E, Andréasson M, Markaki I, Wallom KL, Platt F, Svenningsson P. Glycosphingolipid Changes in Plasma in Parkinson's Disease Independent of Glucosylceramide Levels. Mov Disord 2022. [PMID: 35876461 DOI: 10.1002/mds.29163] [Reference Citation Analysis]
11 Oh HN, Yoo D, Park S, Lee S, Kim WK. Developmental neurotoxicity induced by glutaraldehyde in neuron/astrocyte co-cultured cells and zebrafish. Ecotoxicol Environ Saf 2022;242:113891. [PMID: 35868176 DOI: 10.1016/j.ecoenv.2022.113891] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Lopes MJP, Delmondes GA, Leite GML, Cavalcante DRA, Aquino PÉA, Lima FAV, Neves KRT, Costa AS, Oliveira HD, Bezerra Felipe CF, Pampolha Lima IS, Kerntopf MR, Viana GSB. The Protein-Rich Fraction from Spirulina platensis Exerts Neuroprotection in Hemiparkinsonian Rats by Decreasing Brain Inflammatory-Related Enzymes and Glial Fibrillary Acidic Protein Expressions. J Med Food 2022;25:695-709. [PMID: 35834631 DOI: 10.1089/jmf.2021.0100] [Reference Citation Analysis]
13 Rauschenberger L, Behnke J, Grotemeyer A, Knorr S, Volkmann J, Ip CW. Age-dependent neurodegeneration and neuroinflammation in a genetic A30P/A53T double-mutated α-synuclein mouse model of Parkinson's disease. Neurobiol Dis 2022;171:105798. [PMID: 35750147 DOI: 10.1016/j.nbd.2022.105798] [Reference Citation Analysis]
14 Markovic M, Yeapuri P, Namminga KL, Lu Y, Saleh M, Olson KE, Gendelman HE, Mosley RL. Interleukin-2 expands neuroprotective regulatory T cells in Parkinson’s disease. NeuroImmune Pharmacology and Therapeutics 2022;0. [DOI: 10.1515/nipt-2022-0001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Mata-martínez E, Díaz-muñoz M, Vázquez-cuevas FG. Glial Cells and Brain Diseases: Inflammasomes as Relevant Pathological Entities. Front Cell Neurosci 2022;16:929529. [DOI: 10.3389/fncel.2022.929529] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Satarker S, Bojja SL, Gurram PC, Mudgal J, Arora D, Nampoothiri M. Astrocytic Glutamatergic Transmission and Its Implications in Neurodegenerative Disorders. Cells 2022;11:1139. [PMID: 35406702 DOI: 10.3390/cells11071139] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
17 Mazzetti S, Barichella M, Giampietro F, Giana A, Calogero AM, Amadeo A, Palazzi N, Comincini A, Giaccone G, Bramerio M, Caronni S, Cereda V, Cereda E, Cappelletti G, Rolando C, Pezzoli G. Astrocytes expressing Vitamin D-activating enzyme identify Parkinson's disease. CNS Neurosci Ther 2022. [PMID: 35166042 DOI: 10.1111/cns.13801] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Wang H, Xu C. A Novel Progress: Glial Cells and Inflammatory Pain. ACS Chem Neurosci 2022;13:288-95. [PMID: 35060697 DOI: 10.1021/acschemneuro.1c00607] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Agostini F, Masato A, Bubacco L, Bisaglia M. Metformin Repurposing for Parkinson Disease Therapy: Opportunities and Challenges. Int J Mol Sci 2021;23:398. [PMID: 35008822 DOI: 10.3390/ijms23010398] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
20 Guo H, Zhang Z, Gu T, Yu D, Shi Y, Gao Z, Wang Z, Liu W, Fan Z, Hou W, Wang H, Cai Y. Astrocytic glycogen mobilization participates in salvianolic acid B-mediated neuroprotection against reperfusion injury after ischemic stroke. Exp Neurol 2021;349:113966. [PMID: 34973964 DOI: 10.1016/j.expneurol.2021.113966] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Lee KH, Cha M, Lee BH. Crosstalk between Neuron and Glial Cells in Oxidative Injury and Neuroprotection. Int J Mol Sci 2021;22:13315. [PMID: 34948108 DOI: 10.3390/ijms222413315] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
22 Prasuhn J, Brüggemann N. Gene Therapeutic Approaches for the Treatment of Mitochondrial Dysfunction in Parkinson's Disease. Genes (Basel) 2021;12:1840. [PMID: 34828446 DOI: 10.3390/genes12111840] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
23 Meneghini V, Peviani M, Luciani M, Zambonini G, Gritti A. Delivery Platforms for CRISPR/Cas9 Genome Editing of Glial Cells in the Central Nervous System. Front Genome Ed 2021;3:644319. [PMID: 34713256 DOI: 10.3389/fgeed.2021.644319] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
24 Valori CF, Possenti A, Brambilla L, Rossi D. Challenges and Opportunities of Targeting Astrocytes to Halt Neurodegenerative Disorders. Cells 2021;10:2019. [PMID: 34440788 DOI: 10.3390/cells10082019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
25 Rajib D. Role of neuron specific enolase as a biomarker in Parkinson’s disease. J Neurosci Neurol Disord 2021;5:061-068. [DOI: 10.29328/journal.jnnd.1001052] [Reference Citation Analysis]
26 Cardinale A, Calabrese V, de Iure A, Picconi B. Alpha-Synuclein as a Prominent Actor in the Inflammatory Synaptopathy of Parkinson's Disease. Int J Mol Sci 2021;22:6517. [PMID: 34204581 DOI: 10.3390/ijms22126517] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 15.0] [Reference Citation Analysis]
27 Passaro AP, Lebos AL, Yao Y, Stice SL. Immune Response in Neurological Pathology: Emerging Role of Central and Peripheral Immune Crosstalk. Front Immunol 2021;12:676621. [PMID: 34177918 DOI: 10.3389/fimmu.2021.676621] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
28 Kozicz T, Morava E, Yardeni T. Powering the brain in health and disease. Eur J Neurosci 2021;53:2943-5. [PMID: 33861478 DOI: 10.1111/ejn.15230] [Reference Citation Analysis]
29 Margiotta A. Role of SNAREs in Neurodegenerative Diseases. Cells 2021;10:991. [PMID: 33922505 DOI: 10.3390/cells10050991] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]